These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 28400467)
21. Clinical application of amplicon-based next-generation sequencing in cancer. Chang F; Li MM Cancer Genet; 2013 Dec; 206(12):413-9. PubMed ID: 24332266 [TBL] [Abstract][Full Text] [Related]
22. Comparison of next-generation sequencing and mutation-specific platforms in clinical practice. Hinrichs JW; van Blokland WT; Moons MJ; Radersma RD; Radersma-van Loon JH; de Voijs CM; Rappel SB; Koudijs MJ; Besselink NJ; Willems SM; de Weger RA Am J Clin Pathol; 2015 Apr; 143(4):573-8. PubMed ID: 25780010 [TBL] [Abstract][Full Text] [Related]
23. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine. Paolillo C; Londin E; Fortina P Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004 [TBL] [Abstract][Full Text] [Related]
24. Implementation of Next-Generation Sequencing for Hepatitis B Virus Resistance Testing and Genotyping in a Clinical Microbiology Laboratory. Lowe CF; Merrick L; Harrigan PR; Mazzulli T; Sherlock CH; Ritchie G J Clin Microbiol; 2016 Jan; 54(1):127-33. PubMed ID: 26537448 [TBL] [Abstract][Full Text] [Related]
27. Comparison of three human papillomavirus DNA detection methods: Next generation sequencing, multiplex-PCR and nested-PCR followed by Sanger based sequencing. da Fonseca AJ; Galvão RS; Miranda AE; Ferreira LC; Chen Z J Med Virol; 2016 May; 88(5):888-94. PubMed ID: 26496186 [TBL] [Abstract][Full Text] [Related]
28. Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy. Hagemann IS; Cottrell CE; Lockwood CM Cancer Genet; 2013 Dec; 206(12):420-31. PubMed ID: 24388712 [TBL] [Abstract][Full Text] [Related]
29. Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology. Cronin M; Ross JS Biomark Med; 2011 Jun; 5(3):293-305. PubMed ID: 21657839 [TBL] [Abstract][Full Text] [Related]
30. An integrated genotyping approach for HLA and other complex genetic systems. Nelson WC; Pyo CW; Vogan D; Wang R; Pyon YS; Hennessey C; Smith A; Pereira S; Ishitani A; Geraghty DE Hum Immunol; 2015 Dec; 76(12):928-38. PubMed ID: 26027777 [TBL] [Abstract][Full Text] [Related]
31. Development of a next-generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform. Chan M; Ji SM; Yeo ZX; Gan L; Yap E; Yap YS; Ng R; Tan PH; Ho GH; Ang P; Lee AS J Mol Diagn; 2012 Nov; 14(6):602-12. PubMed ID: 22921312 [TBL] [Abstract][Full Text] [Related]
32. Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers. D'Haene N; Le Mercier M; De Nève N; Blanchard O; Delaunoy M; El Housni H; Dessars B; Heimann P; Remmelink M; Demetter P; Tejpar S; Salmon I PLoS One; 2015; 10(9):e0138245. PubMed ID: 26366557 [TBL] [Abstract][Full Text] [Related]
33. Next-generation sequencing in precision oncology: challenges and opportunities. Kruglyak KM; Lin E; Ong FS Expert Rev Mol Diagn; 2014 Jul; 14(6):635-7. PubMed ID: 24791810 [TBL] [Abstract][Full Text] [Related]
34. Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes. Singh RR; Patel KP; Routbort MJ; Reddy NG; Barkoh BA; Handal B; Kanagal-Shamanna R; Greaves WO; Medeiros LJ; Aldape KD; Luthra R J Mol Diagn; 2013 Sep; 15(5):607-22. PubMed ID: 23810757 [TBL] [Abstract][Full Text] [Related]
35. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material. de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633 [TBL] [Abstract][Full Text] [Related]
36. PathOS: a decision support system for reporting high throughput sequencing of cancers in clinical diagnostic laboratories. Doig KD; Fellowes A; Bell AH; Seleznev A; Ma D; Ellul J; Li J; Doyle MA; Thompson ER; Kumar A; Lara L; Vedururu R; Reid G; Conway T; Papenfuss AT; Fox SB Genome Med; 2017 Apr; 9(1):38. PubMed ID: 28438193 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic yield of targeted next generation sequencing in various cancer types: an information-theoretic approach. Hagemann IS; O'Neill PK; Erill I; Pfeifer JD Cancer Genet; 2015 Sep; 208(9):441-7. PubMed ID: 26227479 [TBL] [Abstract][Full Text] [Related]
39. Clinical mutation assay of tumors: new developments. Starostik P Anticancer Drugs; 2017 Jan; 28(1):1-10. PubMed ID: 27575332 [TBL] [Abstract][Full Text] [Related]
40. A Model Study of In Silico Proficiency Testing for Clinical Next-Generation Sequencing. Duncavage EJ; Abel HJ; Merker JD; Bodner JB; Zhao Q; Voelkerding KV; Pfeifer JD Arch Pathol Lab Med; 2016 Oct; 140(10):1085-91. PubMed ID: 27388684 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]